The firm is developing protein therapies incorporating synthetic amino acids coded for by "unnatural" base pairs developed at The Scripps Research Institute.
The company will work with a University of Copenhagen researcher to develop new synthetic peptide tools for the Syro Wave platform.
The firm sold its bioanalytical and genetic testing businesses to Bostwick Labs as it preps to buy peptide maker GL Biochem.
This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.
The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.
Researchers find that people's genetics influence their success at university, but that it is not the only factor.
In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.